Inhibition of type I collagen gene expression in normal and systemic sclerosis fibroblasts by a specific inhibitor of geranylgeranyl transferase I

J Rosenbloom, B Saitta, S Gaidarova… - … : Official Journal of …, 2000 - Wiley Online Library
… with affinity-purified anti–type I collagen polyclonal antibody (1:200 dilution; Rockland,
Gilbertsville, PA) in 1% BSA. After washing off the primary antibody, a 1:40 dilution of fluorescein-…

[引用][C] Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride levels

M Kodera - CLINICAL IMMUNOLOGY-TOKYO-, 2005

[HTML][HTML] Dyslipidaemia in rheumatological autoimmune diseases

TE Toms, VF Panoulas, GD Kitas - The open cardiovascular …, 2011 - ncbi.nlm.nih.gov
… Alongside these factors, antibodies produced as part of the … , is reduced activity of the enzyme
lipoprotein lipase (LPL) [100], … Systemic sclerosis (SSc) is a condition characterised by skin …

Artifactual hypoglycaemia in systemic sclerosis and Raynaud's phenomenon: a clinical case report and short review

RH Bishay, A Suryawanshi - Case Reports in Endocrinology, 2016 - Wiley Online Library
… Her past medical history was significant for centromere antibody positive systemic sclerosis
with features of the CREST syndrome, … Thyroid function and lipase were within normal limits. …

… -like protein 3 levels: possible correlation with progressive skin sclerosis, digital ulcers and pulmonary vascular involvement in patients with systemic sclerosis.

Y Ichimura, Y Asano, K Akamata… - Acta Dermato …, 2014 - search.ebscohost.com
… Briefly, polystyrene 96-well plates coated with antibodies … horseradish peroxidase conjugated
antibodies against ANGPTL3… ANGPTL3 inhibits the activity of lipoprotein lipase (14), lower …

Serum-mediated oxidative stress from systemic sclerosis patients affects mesenchymal stem cell function

G Fonteneau, C Bony, R Goulabchand… - Frontiers in …, 2017 - frontiersin.org
Objectives Properties of mesenchymal stromal/stem cells (MSCs) from systemic sclerosis (SSc)
patients have been reported to be altered. MSC-based therapy may therefore rely on the …

Clinical trials in systemic sclerosis: lessons learned and outcomes

M Matucci-Cerinic, VD Steen, DE Furst… - Arthritis research & …, 2007 - Springer
The pathogenesis of systemic sclerosis (SSc) is complex and largely unclear. The clinical
heterogeneity of the disease and its progression over a number of years makes the choice of …

Dyslipidemia in systemic lupus erythematosus

MZ Szabó, P Szodoray, E Kiss - Immunologic research, 2017 - Springer
… TG, auto-antibodies can cause the injury of the endothelium, lipoprotein lipase (LPL)
activity can be reduced by circulating inflammatory mediators and antibodies, and increased …

Probable autoimmune hepatitis and systemic sclerosis complicated by reversible posterior leukoencephalopathy syndrome: An unusual association

WH Chang, CJ Chen, CY Liu, MJ Chen… - Advances in …, 2016 - Wiley Online Library
Systemic sclerosis is a multisystem autoimmune rheumatic disorder characterized by …
We report a case of systemic sclerosis associated with probable autoimmune hepatitis that …

Sine Oculis Homeobox Homolog 1 Modulates Early Features of Systemic Sclerosis Skin Fibrosis

N Wareing, T Mills, SD Collum, M Wu, L Revercomb… - papers.ssrn.com
… Polyvinylidene difluoride (PVDF) membranes were blocked with 5% dry milk in TBST for 1
hr and then incubated overnight with primary antibody. HRP conjugated secondary antibody